Table 3 Therapeutic effects of olanzapine.

From: Efficacy of olanzapine as an antiemetic drug for transcatheter arterial chemoembolization for hepatocellular carcinoma

 

Olanzapine group

Control group

P value

n = 31

n = 37

aCR, n(%)

 Overall duration within 120 h

28(90.3)

25(67.6)

< 0.05

 Within 24 h

28(90.3)

33(89.2)

> 0.99

 Within 120 h after 24 h

30(96.8)

28(75.7)

< 0.05

CC, n(%)

 Overall duration within 120 h

27(87.1)

23(62.2)

< 0.05

 Within 24 h

28(90.3)

32(86.5)

0.72

 Within 120 h after 24 h

30(96.8)

25(67.6)

< 0.01

TC, n(%)

 Overall duration within 120 h

26(83.9)

22(59.5)

< 0.05

 Within 24 h

27(87.1)

31(83.8)

0.75

 Within 120 h after 24 h

29(93.5)

24(64.9)

< 0.01

Satisfaction score, n(%)

 0–1/2–3/4–6

29(93.5)/2(6.5)/0(0.0)

12(32.4)/17(45.9)/8(21.6)

< 0.01

  1. aCR; antiemetic complete response, CC; complete control, TC; total control.
Back to article page